Pascal Soriot

Type: Person
Name: Pascal Soriot
First reported Jul 12 2014 - Updated Jul 12 2014 - 1 reports

AstraZeneca to unveil Cambridge plans

The Anglo-Swedish drug maker is to launch a public consultation on the architectural plans for new £330m facility on Friday AstraZeneca will this week unveil the design plans for its new Cambridge hub, which formed a key plank in its defence against US ... [Published Telegraph - Jul 12 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

U.K. fund manager Neil Woodford bets big on AstraZeneca

Plenty of AstraZeneca ($AZN) fans voiced their support for a standalone company when Pfizer ($PFE) tried to take the drugmaker over earlier this year. But actions speak louder than words, and now one vocal advocate is putting his money where his mouth ... [Published FiercePharma - Jul 07 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

European Stocks Mixed, France Lags On Failed Telecom Merger

European stocks gave back early gains and finished in negative territory on Wednesday, as investors remained nervous about tensions in Iraq.The Euro Stoxx 50 index of eurozone bluechip stocks slipped 0.14 percent, but is up 4.7 percent year-to-date.The ... [Published RTTNews.com - Jul 02 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

Alcatel Lucent Leads Gains Among European ADRs on...

Yellen, speaking to the International Monetary Fund, said that while the Fed is mindful of financial stability in setting interest rate policy, it is not the primary focus. In fact, focusing on financial stability could bring undesirable volatility to ... [Published Nasdaq - Jul 02 2014]
First reported Jul 01 2014 - Updated Jul 02 2014 - 1 reports

AstraZeneca : CEO Buys GBP2 Million In Shares (DIRECTOR DEALINGS)

LONDON ( Alliance News ) - AstraZeneca PLC Tuesday said Chief Executive Officer Pascal Soriot bought 46,200 shares at a price of 4,345 pence per share Monday worth GBP2.0 million before expenses.Shares in the biopharmaceutical company were trading at ... [Published 4 Traders - Jul 01 2014]
First reported Jul 01 2014 - Updated Jul 02 2014 - 6 reports

Buzzing: Astrazeneca boss buys £2m shares

The chief executive of Astrazeneca has put his money where his mouth is and invested in £2m-worth of shares in the drugs company. Pascal Soriot purchased 46,200 shares at a cost of 4,345p each. The drug giant turned down a £55-per- share takeover bid ... [Published City A.M. - Jul 02 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

Wednesday newspaper round-up: National Grid, London property, Sports Direct...

Billions of pounds of subsidies could be wasted, according to government-appointed experts who have accused National Grid of exaggerating the risk of blackouts. The energy group this week unveiled new subsidies for power stations to be kept on standby ... [Published London South East - Jul 02 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 4 reports

AstraZeneca chief increases stake

Pascal Soriot buys 46,200 shares at £43.45 each on Monday, increasing by nearly a third his personal stake in Britain’s second-biggest drugmaker ... [Published FT.com - UK News - Jul 01 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

AstraZeneca Chief buys round of shares worth £2m

Natasha RobertsAstraZeneca's Chief Executive Officer, Pascal Soriot, has spent £2m on shares, the drugs giant announced on Tuesday.The director, who has held his role since October 2012, paid 4,345p for each of the 46,200 shares.It follows another large ... [Published BullBearings - Jul 01 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

AstraZeneca PLC : Director/PDMR Shareholding

Transaction by Person Discharging Managerial ResponsibilitiesDisclosure Rule DTR 3.1.4On 30 June 2014, Pascal Soriot, a Director of the Company, notified us that, on 30 June 2014, he purchased 46,200 AstraZeneca PLC Ordinary Shares of $0.25 each at a ... [Published Investegate - Jul 01 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

Astrazeneca knocked by US regulator drug verdict

UK PHARMA giant Astrazeneca was dealt a blow yesterday when US regulators knocked back its bid to gain accelerated approval for a new ovarian cancer drug.Astrazeneca’s pipeline is under particular scrutiny after chief exec Pascal Soriot boasted of a bright ... [Published City A.M. - Jun 27 2014]
First reported Jun 23 2014 - Updated Jun 24 2014 - 1 reports

FDA review red-flags AstraZeneca's case for ovarian cancer drug olaparib

AZ CEO Pascal SoriotAstraZeneca's ($AZN) reconstructed case for the cancer drug olaparib is built on the fundamental premise that the new management team at the pharma giant is a whole lot smarter than the old crew. After a retrospective analysis found ... [Published FierceBiotech - Jun 23 2014]

More Content

All (186) | News (158) | Reports (0) | Blogs (23) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
AstraZeneca share price: R&D arm teams up with ... [Published Invezz - Jul 22 2014]
AstraZeneca reveals designs for new global R&D ... [Published Pharma Letter - Jul 20 2014]
AstraZeneca share price: Drugmaker unveils Camb... [Published Invezz - Jul 18 2014]
Is Roche Eyeing Up A Bid For AstraZeneca plc? [Published Yahoo! UK and Ireland - Jul 18 2014]
AstraZeneca to unveil Cambridge plans [Published Telegraph - Jul 12 2014]
U.K. pols ready for Pfizer's return, AZ cozies ... [Published FierceBiotech - Jul 10 2014]
AbbVie Retracts CEO Claims of Shire Bid Support [Published TheStreet.com - Jul 09 2014]
AbbVie Retracts CEO Claims of Shire Bid Support [Published The Street Latest - Jul 09 2014]
U.K. fund manager Neil Woodford bets big on Ast... [Published FiercePharma - Jul 07 2014]
AstraZeneca share price: High-profile investor ... [Published Invezz - Jul 07 2014]
AbbVie battle for Shire: why this time it's dif... [Published Telegraph - Jul 05 2014]
Gross income inequality puts corporate salaries... [Published World Finance - Jul 04 2014]
MARKET REPORT: New World Resources' value crash... [Published Mail Online UK - Jul 02 2014]
MARKET REPORT: New World Resources' value crash... [Published This Is Money - Jul 02 2014]
European Stocks Mixed, France Lags On Failed Te... [Published RTTNews.com - Jul 02 2014]
Alcatel Lucent Leads Gains Among European ADRs ... [Published Nasdaq - Jul 02 2014]
EUROPE MARKETS : Alcatel, Roche Up In Europe, B... [Published 4 Traders - Jul 02 2014]
Is AstraZeneca plc’s Latest Director Deal A Gam... [Published Yahoo! UK and Ireland - Jul 02 2014]
AstraZeneca share price: Chief executive increa... [Published Invezz - Jul 02 2014]
Wednesday newspaper round-up: National Grid, Lo... [Published London South East - Jul 02 2014]
3 Ocado’s long-awaited profit fails to convince... [Published Irish Times - Jul 02 2014]
Buzzing: Astrazeneca boss buys £2m shares [Published City A.M. - Jul 02 2014]
AstraZeneca PLC CEO Wagers $3.4 Million On Shares [Published BioSpace - Jul 01 2014]
Pascal Soriot snaps up £2m in AstraZeneca shares [Published Telegraph - Jul 01 2014]
AstraZeneca CEO purchases 46.2K shares, Reuters... [Published Yahoo! Finance - Jul 01 2014]
AstraZeneca chief increases stake [Published FT.com - UK News - Jul 01 2014]
AstraZeneca chief increases stake [Published FT.com - Companies - Jul 01 2014]
AstraZeneca chief increases stake [Published FT.com - Companies UK - Jul 01 2014]
AstraZeneca chief increases stake [Published FT.com - Health - Jul 01 2014]
AstraZeneca Chief buys round of shares worth £2m [Published BullBearings - Jul 01 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
"Not My Pay" says AZ's Soriot [Published The Big Red Biotech Blog - Jun 02 2014]
Fierce Pharma characterizes AZ's CEO Pascal Soriot as bristling to the idea that executive pay (including his own) should be tied to the sales forecast that he and board chairman Leif Johansson tossed out there as they tried to fend off Pfizer's takeover ...
Pfizer Decides AstraZeneca Isn’t Worth the Trou... [Published Wall St. Cheat Sheet - May 27 2014]
Source: Thinkstock After months of the chase, it seems Pfizer Inc.  ( NYSE:PFE ) has finally given up on its pursuit of British-Swedish drugmaker AstraZeneca Group Plc  ( NYSE:AZN ). The company announced in a statement on Monday that it would ...
Frontrunning: May 27 [Published Zero Hedge - May 27 2014]
Vietnam, China trade accusations after Vietnamese fishing boat sinks ( Reuters ) SEC Set to Spur Exchange Trading ( WSJ ) Bank of Japan quietly eyes stimulus exit ( Reuters ) Japan Risks Low Growth Even as Easing Spurs Inflation ( BBG ) Hello Japan: Bond ...
How AstraZeneca escaped Pfizer's clutches this ... [Published Yahoo! Health News - May 27 2014]
By Ben Hirschler LONDON (Reuters) - On a sunny day in San Francisco last January, AstraZeneca Chief Executive Pascal Soriot was on his way to the Westin St. Francis hotel on Union Square to give investors some unexpectedly good news. What shareh... ...
The Top 5 Biggest Pharma Deals of 2013 [Published Wall St. Cheat Sheet - May 17 2014]
Source: Thinkstock 5. AstraZeneca/Bristol-Myers Squibb Co. AstraZeneca Group Plc  ( NYSE:AZN ) and Bristol-Myers Squibb Co.  ( NYSE:BMY ) had been in a long-term partnership for six years before Bristol-Myers Squibb decided that it wanted to jump ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Director/PDMR Shareholding [Published GlobeNewswire: Acquisitions News - Jul 01 2014]
ASTRAZENECA UPDATES ON THE RAPID PROGRESS OF ON... [Published GlobeNewswire: Advertising News - Jun 03 2014]
ASTRAZENECA BOARD REJECTS PFIZER’S FINAL PROPOSAL [Published AstraZeneca - May 19 2014]
Continuing progress in accelerating late stage ... [Published AstraZeneca - May 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.